Target intelligence / Profile preview

Death Receptor Pathway (Fas Ligand and TRAIL) (N/A)

Target
N/A
Molecular classification
Signaling Pathway, Apoptosis Pathway, Receptor-Ligand Interaction
01

Overview

The death receptor pathway, primarily mediated by Fas Ligand (FasL) and TRAIL, is a crucial mechanism for inducing apoptosis in tumor cells. Upon ligand binding to their respective receptors (Fas, DR4, DR5), the pathway initiates a cascade leading to caspase activation and cell death. However, tumor cells often develop resistance mechanisms or exploit non-apoptotic signaling functions of this pathway, making it a complex but important therapeutic target in cancer.

Other names
Fas Ligand PathwayTRAIL PathwayCD95L PathwayTNFSF10 PathwayApoptosis Signaling via Death Receptors
02

Mechanism of action

Activation of death receptors (Fas, TRAILR1/DR4, TRAILR2/DR5) leads to DISC formation, caspase-8 activation, and subsequent executioner caspase activation, resulting in apoptosis. Can also trigger non-apoptotic signaling pathways depending on cellular context.

03

Biological functions

ApoptosisCell deathSignal transductionImmune responseCytokine productionCell proliferationCell migrationDifferentiation
04

Disease associations

CancerAutoimmune diseasesInflammation
05

Safety considerations

Hepatotoxicity (TRAIL-based therapies)Off-target effects on normal cellsInduction of non-apoptotic signaling pathways promoting tumor progressionDevelopment of resistance mechanismsPotential for inflammatory responses
06

Interacting drugs

TRAIL-based therapeutics

3 more in the full profile.

07

Biomarkers

Fas expressionFasL expressionTRAIL expressionDR4 expressionDR5 expressionDcR1 expressionDcR2 expressionFADD expressionCaspase-8 activityFLIP expression

Beyond the preview

Go deeper on Death Receptor Pathway (Fas Ligand and TRAIL) (N/A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Death Receptor Pathway (Fas Ligand and TRAIL) (N/A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call